TYBR Health, a medical technology and regenerative medicine company focused on transforming the post-surgery experience, has secured $30.0M in Series A funding. This significant capital infusion is set to accelerate its mission to empower patients on their healing journey and simplify recovery, moving beyond traditional approaches to post-operative care.
The company is dedicated to developing cutting-edge biomaterial therapies. These innovative solutions are designed to reduce complications and enhance patient outcomes, aligning with TYBR Health's vision to revolutionize patient recovery and provide more effective pathways to wellness.
